Back

Circulating Extracellular Vesicle miRNAs for Distinguishing Prostate Cancer and Benign Prostatic Hyperplasia

Ding, T.; Zhang, X.; Yu, L.

2026-02-19 urology
10.64898/2026.02.18.26346569 medRxiv
Show abstract

Our previous studies identified three microRNAs (miR-92a-1-5p, miR-375 and miR-148a-3p) potentially associated with prostate cancer (PCa), particularly in advanced stages such as bone-metastatic PCa. To evaluate their clinical diagnostic utility, we isolated extracellular vesicles (EVs) from the plasma of patients with benign prostatic hyperplasia (BPH) and PCa (including localized and bone-metastatic disease). The absolute quantification of these three miRNAs within plasma EVs was performed using digital PCR. Results indicated that miR-148a-3p alone possessed a good ability to discriminate between PCa and BPH. Notably, a combined panel of all three miRNAs demonstrated improved diagnostic performance, achieving an area under the curve (AUC) of 0.736 for distinguishing PCa from BPH. These findings suggest that the plasma EV-derived miRNA panel (miR-92a-3p, miR-148a-3p, and miR-375-3p) holds promise as an auxiliary diagnostic biomarker for PCa and may aid in identifying bone metastasis.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.